-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Uv+MzmWIQ76ACJHjsn1IxvxLbrHxNq6H3Bl5OIjzQTk0BzMqLYy1E4dMGfWtNeLM G2hx/McVU5EBn8QuL04CJw== 0001209191-06-055744.txt : 20061024 0001209191-06-055744.hdr.sgml : 20061024 20061024160723 ACCESSION NUMBER: 0001209191-06-055744 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061023 FILED AS OF DATE: 20061024 DATE AS OF CHANGE: 20061024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GILLIS STEVEN CENTRAL INDEX KEY: 0001229592 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33054 FILM NUMBER: 061160359 BUSINESS ADDRESS: STREET 1: 4311 FOREST AVE. CITY: MERCER ISLAND STATE: WA ZIP: 98040 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Trubion Pharmaceuticals, Inc CENTRAL INDEX KEY: 0001298521 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 2401 14TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2068380500 MAIL ADDRESS: STREET 1: 2401 14TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 bos24291_bos21sg.xml MAIN DOCUMENT DESCRIPTION X0202 4 2006-10-23 0001298521 Trubion Pharmaceuticals, Inc TRBN 0001229592 GILLIS STEVEN ARCH VENTURE PARTNERS 1000 2ND AVE., SUITE 3700 SEATTLE WA 98104 1 0 0 1 10% Indirect Owner Common Stock 2006-10-23 2006-10-23 4 C 1 2288486 0.00 A 2312406 I See Footnotes Series A Preferred Stock 0.00 2006-10-23 2006-10-23 4 C 1 1047724 0.00 D 2006-10-23 2006-10-23 Common Stock 1047724 0 I See Footnotes Series B Preferred Stock 0.00 2006-10-23 2006-10-23 4 C 1 1240762 0.00 D 2006-10-23 2006-10-23 Common Stock 1240762 0 I See Footnotes Represents (a) 2,165,101 shares of common stock held by ARCH Venture Fund V, L.P., (b) 14,503 shares of common stock held by ARCH V Entrepreneurs Fund, L.P., and (c) 132,802 shares of common stock held by Healthcare Focus Fund, L.P. Represents (a) 979,880 shares of Series A Preferred stock held by ARCH Venture Fund V, L.P., (b) 6,511 shares of Series A Preferred Stock held by ARCH V Entrepreneurs Fund, L.P., and (c) 61,333 shares of Series A Preferred stock held by Healthcare Focus Fund, L.P. Represents (a) 1,161,459 shares of Series B Preferred stock held by ARCH Venture Fund V, L.P., (b) 7,834 shares of Series B Preferred Stock held by ARCH V Entrepreneurs Fund, L.P., and (c) 71,469 shares of Series B Preferred stock held by Healthcare Focus Fund, L.P. Reporting person holds the title of limited partner of ARCH Venture Fund V, L.P. and disclaims beneficial ownership of shares owned by these entitites. 1-for-1 conversion of preferred stock into common stock effective on the closing of the Issuer's initial public offering. /s/ Lauree Seko, Attorney-In-Fact on behalf of Steven Gillis 2006-10-23 -----END PRIVACY-ENHANCED MESSAGE-----